Valentina Arena

ORCID

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 12

Top Venues

Leukemia & lymphoma

Blood advances

Blood

This page only lists publications with an associated author ORCID identifier.

Publications

Adriano Venditti, Alfonso Piciocchi, Anna Candoni, Valentina Arena, Raffaele Palmieri, Carla Filì, Angelo Michele Carella, Valeria Calafiore, Roberto Cairoli, Paolo De Fabritiis, Gabriella Storti, Prassede Salutari, Francesco Lanza, Giovanni Martinelli, Antonio Curti, Mario Luppi, Claudia Ingrosso, Maria Paola Martelli, Antonio Cuneo, Francesco Albano, Antonino Mulè, Agostino Tafuri, Laura Cudillo, Alessia Tieghi, Nicola Stefano Fracchiolla, Debora Capelli, Silvia Maria Trisolini, Caterina Alati, Edoardo La Sala, Luca Maurillo, Maria Ilaria Del Principe, Maria Antonietta Irno Consalvo, Maria Domenica Divona, Tiziana Ottone, Raffaella Cerretti, Giuseppe Sconocchia, Maria Teresa Teresa Voso, Paola Fazi, Marco Vignetti, Francesco Buccisano
Risk-adapted MRD-directed therapy for young adults with acute myeloid leukemia: 6-year update of the GIMEMA AML1310 trial. Blood advances 8 (16) (2024)
Adriano Venditti, Alfonso Piciocchi, Anna Candoni, Valentina Arena, Raffaele Palmieri, Carla Fili, Angelo Michele Carella, Valeria Calafiore, Roberto Cairoli, Paolo De Fabritiis, Gabriella Storti, Prassede Salutari, Francesco Lanza, Giovanni Martinelli, Antonio Curti, Mario Luppi, Claudia Ingrosso, Maria Paola Martelli, Antonio Cuneo, Francesco Albano, Antonino Mulè, Agostino Tafuri, Laura Cudillo, Alessia Tieghi, Nicola Stefano Fracchiolla, Debora Capelli, Silvia Maria Trisolini, Caterina Alati, Edoardo La Sala, Luca Maurillo, Maria Ilaria Del Principe, Maria Antonietta Irno Consalvo, Maria Domenica Divona, Tiziana Ottone, Raffaella Cerretti, Giuseppe Sconocchia, Maria Teresa Teresa Voso, Paola Fazi, Marco Vignetti, Francesco Buccisano
RISK-ADAPTED MRD-DIRECTED THERAPY FOR YOUNG ACUTE MYELOID LEUKEMIA ADULTS: 6-YEAR UPDATE OF THE GIMEMA AML1310 TRIAL. Blood advances (2024)
Sabina Chiaretti, Akram Taherinasab, Irene Della Starza, Martina Canichella, Michela Ansuinelli, Maria Stefania De Propris, Monica Messina, Orietta Spinelli, Alessandra Santoro, Lucia Anna De Novi, Deborah Cardinali, Mattia Schipani, Valentina Arena, Renato Bassan, Anna Guarini, Robin Foà
ZNF384 rearrangement is the most frequent genetic lesion in adult PH-negative and Ph-like-negative B-other acute lymphoblastic leukemia. Biological and clinical findings. Leukemia & lymphoma 64 (2) (2022)
Sabina Chiaretti, Akram Taherinasab, Irene Della Starza, Martina Canichella, Michela Ansuinelli, Maria Stefania De Propris, Monica Messina, Orietta Spinelli, Alessandra Santoro, Lucia Anna De Novi, Deborah Cardinali, Mattia Schipani, Valentina Arena, Renato Bassan, Anna Guarini, Robin Foà
ZNF384 rearrangement is the most frequent genetic lesion in adult PH-negative and Ph-like-negative B-other acute lymphoblastic leukemia. Biological and clinical findings. Leukemia & lymphoma (2022)
Sabina Chiaretti, Akram Taherinasab, Irene Della Starza, Martina Canichella, Michela Ansuinelli, Maria Stefania De Propris, Monica Messina, Orietta Spinelli, Alessandra Santoro, Lucia Anna De Novi, Deborah Cardinali, Mattia Schipani, Valentina Arena, Renato Bassan, Anna Guarini, Robin Foà
ZNF384 rearrangement is the most frequent genetic lesion in adult PH-negative and Ph-like-negative B-other acute lymphoblastic leukemia. Biological and clinical findings. Leukemia & lymphoma 64 (2) (2022)
Sabina Chiaretti, Akram Taherinasab, Irene Della Starza, Martina Canichella, Michela Ansuinelli, Maria Stefania De Propris, Monica Messina, Orietta Spinelli, Alessandra Santoro, Lucia Anna De Novi, Deborah Cardinali, Mattia Schipani, Valentina Arena, Renato Bassan, Anna Guarini, Robin Foà
ZNF384 rearrangement is the most frequent genetic lesion in adult PH-negative and Ph-like-negative B-other acute lymphoblastic leukemia. Biological and clinical findings. Leukemia & lymphoma 64 (2) (2022)
Sabina Chiaretti, Akram Taherinasab, Irene Della Starza, Martina Canichella, Michela Ansuinelli, Maria Stefania De Propris, Monica Messina, Orietta Spinelli, Alessandra Santoro, Lucia Anna De Novi, Deborah Cardinali, Mattia Schipani, Valentina Arena, Renato Bassan, Anna Guarini, Robin Foà
ZNF384 rearrangement is the most frequent genetic lesion in adult PH-negative and Ph-like-negative B-other acute lymphoblastic leukemia. Biological and clinical findings. Leukemia & lymphoma 64 (2) (2022)
Anna Maria Testi, Mazin Faisal Al-Jadiry, Hasanein Habeeb Ghali, Samaher Abdulrazzaq Fadhil, Amir Fadhil Al-Darraji, Raghad Majid Al-Saeed, Ahmed Hatem Sabhan, Safaa A Faraj Al-Badri, Wisan Majeed Abed, Najiha Ahmed Ameen, Ruaa Zaki Al-Tameemi, Arabiya Idan Al-Assaf, Maria Luisa Moleti, Valentina Arena, Alfonso Piciocchi, Robin Foà, Salma Abbas Al-Hadad
Childhood acute promyelocytic leukemia in a pediatric cancer referral center in Baghdad, Iraq. Improved results with ATRA extended consolidation. Leukemia & lymphoma 63 (12) (2022)
Sabina Chiaretti, Akram Taherinasab, Irene Della Starza, Martina Canichella, Michela Ansuinelli, Maria Stefania De Propris, Monica Messina, Orietta Spinelli, Alessandra Santoro, Lucia Anna De Novi, Deborah Cardinali, Mattia Schipani, Valentina Arena, Renato Bassan, Anna Guarini, Robin Foà
ZNF384 rearrangement is the most frequent genetic lesion in adult PH-negative and Ph-like-negative B-other acute lymphoblastic leukemia. Biological and clinical findings. Leukemia & lymphoma 64 (2) (2022)
Sabina Chiaretti, Akram Taherinasab, Irene Della Starza, Martina Canichella, Michela Ansuinelli, Maria Stefania De Propris, Monica Messina, Orietta Spinelli, Alessandra Santoro, Lucia Anna De Novi, Deborah Cardinali, Mattia Schipani, Valentina Arena, Renato Bassan, Anna Guarini, Robin Foà
ZNF384 rearrangement is the most frequent genetic lesion in adult PH-negative and Ph-like-negative B-other acute lymphoblastic leukemia. Biological and clinical findings. Leukemia & lymphoma 64 (2) (2022)
Francesco Buccisano, Raffaele Palmieri, Alfonso Piciocchi, Valentina Arena, Anna Candoni, Lorella Melillo, Valeria Calafiore, Roberto Cairoli, Paolo De Fabritiis, Gabriella Storti, Prassede Salutari, Francesco Lanza, Giovanni Martinelli, Mario Luppi, Saveria Capria, Luca Maurillo, Maria Ilaria Del Principe, Giovangiacinto Paterno, Maria Antonietta Irno Consalvo, Tiziana Ottone, Serena Lavorgna, Maria Teresa Teresa Voso, Paola Fazi, Marco Vignetti, William Arcese, Adriano Venditti
ELN2017 risk stratification improves outcome prediction when applied to the prospective GIMEMA AML1310 protocol. Blood advances (2021)
Gian Matteo Rigolin, Ilaria Del Giudice, Maria Antonella Bardi, Aurora Melandri, Rocio Edith García-Jacobo, Francesca Cura, Sara Raponi, Caterina Ilari, Luciana Cafforio, Alfonso Piciocchi, Valentina Arena, Gianluigi Reda, Francesco Albano, Stefano Molica, Paolo Sportoletti, Livio Trentin, Monia Marchetti, Mauro Nanni, Ilaria Del Giudice, Paola Mariglia, Marco Vignetti, Anna Rita Guarini, Francesca Romana Mauro, Robin Foà, Antonio Cuneo
COMPLEX KARYOTYPE IN UNFIT PATIENTS WITH CLL TREATED WITH IBRUTINIB AND RITUXIMAB. THE GIMEMA LLC1114 PHASE 2 STUDY. Blood (2021)

Valentina Arena.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Valentina Arena